Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case Reports

Fitrah Utari Bakti,1,* Irna Sufiawati2,* 1Oral Medicine Residency, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia; 2Department of Oral Medicine, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia*These authors contributed equally to this work...

Full description

Saved in:
Bibliographic Details
Main Authors: Bakti FU, Sufiawati I
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:International Medical Case Reports Journal
Subjects:
Online Access:https://www.dovepress.com/clinical-activity-of-behcets-disease-associated-with-sars-cov-2-and-he-peer-reviewed-fulltext-article-IMCRJ
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544153586991104
author Bakti FU
Sufiawati I
author_facet Bakti FU
Sufiawati I
author_sort Bakti FU
collection DOAJ
description Fitrah Utari Bakti,1,* Irna Sufiawati2,* 1Oral Medicine Residency, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia; 2Department of Oral Medicine, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia*These authors contributed equally to this workCorrespondence: Irna Sufiawati, Department of Oral Medicine, Faculty of Dentistry, Universitas Padjadjaran, Jl. Sekeloa Selatan No. 1, Bandung, West Java, 40132, Indonesia, Email irna.sufiawati@fkg.unpad.ac.idIntroduction: The Behçet’s Disease Current Activity Form (BDCAF) is crucial for monitoring the progression and treatment efficacy of Behçet’s Disease (BD), an autoimmune disorder that can be triggered or exacerbated by viral infections. Herpes simplex virus type 1 (HSV-1) has long been recognized as a potential trigger for BD, as it can induce systemic inflammation and exacerbate symptoms. In contrast, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has recently emerged and may also initiate or worsen BD symptoms. This report examines three BD cases with oral manifestations specifically triggered by HSV-1 and SARS-CoV-2, comparing their clinical activity and treatment responses.Case: Three female patients, aged 29, 24, and 41 years, presented to the Oral Medicine Department with complaints of canker sores, along with genital and skin lesions and red eyes. Intraoral examination showed ulcerative, erosive, and white plaque lesions throughout the oral mucosa. The first patient was confirmed to have COVID-19 by the SARS-CoV-2 RNA test. The second and third patients had a two-year history of recurrent oral ulcerations with reactive IgG anti-HSV-1 tests. All patients were diagnosed with BD according to the International Criteria for Behcet’s Disease. The BDCAF measurements were conducted, showing a BD activity index score of 4 for the COVID-19-positive patient, while scores of 6 and 7 were recorded for the other two patients with seropositive HSV-1.Case Management: Medications provided include corticosteroid, antimetabolite, analgesic, antiviral, antifungal, antiseptic mouthwash, and multivitamin. All patients showed good clinical improvement after treatment.Conclusion: The BD activity index scores of a BD patient with COVID-19 were lower than those with HSV-1 infection. This difference may be due to the recent SARS-CoV-2 infection in the patient, whereas reactivation of chronic latent HSV-1 in the other patients likely contributed to a longer history of clinical manifestations, resulting in increased disease activity.Keywords: autoimmune disease, Behcet’s disease, SARS-CoV-2, HSV-1
format Article
id doaj-art-afcbdf1bf0664accbf8ba6d23a6b8714
institution Kabale University
issn 1179-142X
language English
publishDate 2025-01-01
publisher Dove Medical Press
record_format Article
series International Medical Case Reports Journal
spelling doaj-art-afcbdf1bf0664accbf8ba6d23a6b87142025-01-12T16:52:42ZengDove Medical PressInternational Medical Case Reports Journal1179-142X2025-01-01Volume 18415299141Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case ReportsBakti FUSufiawati IFitrah Utari Bakti,1,* Irna Sufiawati2,* 1Oral Medicine Residency, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia; 2Department of Oral Medicine, Faculty of Dentistry, Universitas Padjadjaran, Bandung, Indonesia*These authors contributed equally to this workCorrespondence: Irna Sufiawati, Department of Oral Medicine, Faculty of Dentistry, Universitas Padjadjaran, Jl. Sekeloa Selatan No. 1, Bandung, West Java, 40132, Indonesia, Email irna.sufiawati@fkg.unpad.ac.idIntroduction: The Behçet’s Disease Current Activity Form (BDCAF) is crucial for monitoring the progression and treatment efficacy of Behçet’s Disease (BD), an autoimmune disorder that can be triggered or exacerbated by viral infections. Herpes simplex virus type 1 (HSV-1) has long been recognized as a potential trigger for BD, as it can induce systemic inflammation and exacerbate symptoms. In contrast, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has recently emerged and may also initiate or worsen BD symptoms. This report examines three BD cases with oral manifestations specifically triggered by HSV-1 and SARS-CoV-2, comparing their clinical activity and treatment responses.Case: Three female patients, aged 29, 24, and 41 years, presented to the Oral Medicine Department with complaints of canker sores, along with genital and skin lesions and red eyes. Intraoral examination showed ulcerative, erosive, and white plaque lesions throughout the oral mucosa. The first patient was confirmed to have COVID-19 by the SARS-CoV-2 RNA test. The second and third patients had a two-year history of recurrent oral ulcerations with reactive IgG anti-HSV-1 tests. All patients were diagnosed with BD according to the International Criteria for Behcet’s Disease. The BDCAF measurements were conducted, showing a BD activity index score of 4 for the COVID-19-positive patient, while scores of 6 and 7 were recorded for the other two patients with seropositive HSV-1.Case Management: Medications provided include corticosteroid, antimetabolite, analgesic, antiviral, antifungal, antiseptic mouthwash, and multivitamin. All patients showed good clinical improvement after treatment.Conclusion: The BD activity index scores of a BD patient with COVID-19 were lower than those with HSV-1 infection. This difference may be due to the recent SARS-CoV-2 infection in the patient, whereas reactivation of chronic latent HSV-1 in the other patients likely contributed to a longer history of clinical manifestations, resulting in increased disease activity.Keywords: autoimmune disease, Behcet’s disease, SARS-CoV-2, HSV-1https://www.dovepress.com/clinical-activity-of-behcets-disease-associated-with-sars-cov-2-and-he-peer-reviewed-fulltext-article-IMCRJautoimmune diseasebehcet's diseasesars-cov-2hsv-1
spellingShingle Bakti FU
Sufiawati I
Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case Reports
International Medical Case Reports Journal
autoimmune disease
behcet's disease
sars-cov-2
hsv-1
title Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case Reports
title_full Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case Reports
title_fullStr Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case Reports
title_full_unstemmed Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case Reports
title_short Clinical Activity of Behcet’s Disease Associated with SARS-CoV-2 and Herpes Simplex Virus: Insights from Three Case Reports
title_sort clinical activity of behcet rsquo s disease associated with sars cov 2 and herpes simplex virus insights from three case reports
topic autoimmune disease
behcet's disease
sars-cov-2
hsv-1
url https://www.dovepress.com/clinical-activity-of-behcets-disease-associated-with-sars-cov-2-and-he-peer-reviewed-fulltext-article-IMCRJ
work_keys_str_mv AT baktifu clinicalactivityofbehcetrsquosdiseaseassociatedwithsarscov2andherpessimplexvirusinsightsfromthreecasereports
AT sufiawatii clinicalactivityofbehcetrsquosdiseaseassociatedwithsarscov2andherpessimplexvirusinsightsfromthreecasereports